...
首页> 外文期刊>AIDS Research and Human Retroviruses >Genetic variation in the HR region of the env gene of HIV: A perspective for resistance to HIV fusion inhibitors.
【24h】

Genetic variation in the HR region of the env gene of HIV: A perspective for resistance to HIV fusion inhibitors.

机译:HIV env基因的HR区域的遗传变异:对HIV融合抑制剂抗性的观点。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

HIV fusion inhibitors may be classified into three groups. Peptides binding to HR1 include T1249, C30, and T20 (enfuvirtide). Peptides binding to HR2 include 5-helix. XTT formazan, NB-2, and NB-64 are nonpeptide fusion inhibitors. Genotypic testing for drug resistance is used more commonly than phenotypic testing because of its lower cost, wider availability, and shorter turnaround time. The aim of the study was to predict the efficacy of fusion inhibitors for AIDS patients in our population. A total of 100 specimens were collected. The viral RNA was isolated and nucleotides of the required regions were sequenced using the BigDye terminator method. It is concluded from this study that viruses in our population may show resistance to C30 and T20 whereas the other fusion inhibitors may be effectively used for our population.
机译:HIV融合抑制剂可分为三类。与HR1结合的肽包括T1249,C30和T20(恩夫韦肽)。与HR2结合的肽包括5-螺旋。 XTT formazan,NB-2和NB-64是非肽融合抑制剂。基因型检测耐药性比表型检测更常用,因为它的成本更低,可用性更广且周转时间更短。该研究的目的是预测融合抑制剂对我国人群艾滋病患者的疗效。总共收集了100个样本。分离病毒RNA,并使用BigDye终止子方法对所需区域的核苷酸进行测序。从这项研究得出的结论是,我们人群中的病毒可能显示出对C30和T20的抗性,而其他融合抑制剂可能有效地用于我们的人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号